AMAG Pharmaceuticals shares have climbed 46 percent since the beginning of the year. The stock has decreased 18 percent in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) …
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on October 12th, 2017 at $17.73. In approximately 3 months, Amag Pharmaceuti has returned 25.25% as of today's recent price of $13.25. Amag
On Tuesday, shares in Advanced Accelerator Applications S.A. recorded a trading volume of 17,797 shares. The stock ended the session 0.13% higher at $82.12. The Company's shares have gained 12.63% over the previous three months …
On Tuesday, shares in Advanced Accelerator Applications S.A. recorded a trading volume of 17,797 shares. The stock
WBOC2mon
AMAG announced commercial launch of its new product Intrarosa. This is the first and only FDA approved, local non-estrogen treatment without any boxed warning. The stock is trading close to 52 weeks low and may benefit from …
the Board of Directors of AMAG approved awards to Ms. Berns of (i) an option to purchase 20,000 shares of common stock and (ii) 9,000 restricted stock units. The option will have an exercise price equal to the closing price of AMAG's …
These are some of the issues facing our Zacks Bear of the Day: AMAG Pharmaceuticals ( AMAG ... As you can see below, AMAG's stock price peaked in 2015, and fell through 2016. The company began to stabilize in late 2016, but …
Nasdaq11mon
Inc. AMAG. Shares have lost about 6.6% in the past month, underperforming the market. Will the recent negative trend continue leading up to the stock's next earnings release, or is it due for a breakout? Before we dive into how investors …
It has been about a month since the last earnings report for AMAG Pharmaceuticals, Inc. AMAG. Shares have lost about 15.6% in that time frame, underperforming the market . Will the recent negative trend continue leading up to the …